Children's Hospital of Philadelphia Foundation

Children's Hospital of Philadelphia Foundation is a declared insider at 2 companies; the most frequent names are Spark Therapeutics, Inc. and Aevi Genomic Medicine, LLC. The record holds 16 filings, for trades running from 4 February 2015 to 3 February 2020.

Market trades split into 2 purchases (€4.2M) and 7 sales (€450.0M). The net balance comes to €445.9M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 option exercises.

The latest filing, published on 5 February 2020, reports a transaction in Aevi Genomic Medicine, LLC. The last insider purchase was made public on 17 August 2018, 3,005 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.